GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 172 filers reported holding GW PHARMACEUTICALS PLC in Q2 2017. The put-call ratio across all filers is 1.32 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $250,000 | +88.0% | 1,152 | 0.0% | 0.01% | +30.0% |
| Q4 2020 | $133,000 | +44.6% | 1,152 | +22.3% | 0.01% | +66.7% |
| Q3 2020 | $92,000 | -14.8% | 942 | +6.9% | 0.01% | -25.0% |
| Q2 2020 | $108,000 | +40.3% | 881 | 0.0% | 0.01% | +14.3% |
| Q1 2020 | $77,000 | -25.2% | 881 | -10.2% | 0.01% | -12.5% |
| Q4 2019 | $103,000 | +2.0% | 981 | +12.0% | 0.01% | -11.1% |
| Q3 2019 | $101,000 | -33.1% | 876 | 0.0% | 0.01% | -25.0% |
| Q2 2019 | $151,000 | +16.2% | 876 | +13.5% | 0.01% | +9.1% |
| Q1 2019 | $130,000 | +1200.0% | 772 | -22.8% | 0.01% | +1000.0% |
| Q4 2018 | $10,000 | -92.5% | 1,000 | +30.4% | 0.00% | -90.9% |
| Q3 2018 | $133,000 | +54.7% | 767 | -5.8% | 0.01% | +57.1% |
| Q2 2018 | $86,000 | 0.0% | 814 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $86,000 | -21.8% | 814 | -2.4% | 0.01% | -30.0% |
| Q4 2017 | $110,000 | -23.6% | 834 | -41.3% | 0.01% | +11.1% |
| Q3 2017 | $144,000 | +0.7% | 1,420 | 0.0% | 0.01% | -10.0% |
| Q2 2017 | $143,000 | – | 1,420 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 390,000 | $45,010,000 | 7.31% |
| Copernicus Capital Management, LLC | 2,788 | $322,000 | 5.02% |
| Integral Health Asset Management, LLC | 72,500 | $8,367,000 | 2.49% |
| Parkman Healthcare Partners LLC | 81,573 | $9,414,000 | 2.41% |
| AdvisorShares Investments LLC | 66,317 | $7,654,000 | 1.78% |
| Tri Locum Partners LP | 40,159 | $4,635,000 | 1.68% |
| ETF MANAGERS GROUP, LLC | 621,361 | $71,711,000 | 1.57% |
| Redmile Group, LLC | 815,681 | $94,138,000 | 1.14% |
| Redwood Investments, LLC | 108,999 | $12,580,000 | 1.07% |
| ROOSEVELT INVESTMENT GROUP LLC | 127,885 | $14,759,000 | 1.05% |